Publications by authors named "Wen-Shuai Cui"

Article Synopsis
  • A study was conducted comparing the effectiveness of two COVID-19 treatments: azvudine and nirmatrelvir/ritonavir, involving 576 patients with varying levels of treatment.
  • Results showed that while both treatments had similar symptoms, azvudine led to a quicker recovery from weakness, but nirmatrelvir/ritonavir was more effective in reducing mortality in severe cases.
  • Ultimately, azvudine is suggested for non-severe cases with weakness, while nirmatrelvir/ritonavir is recommended for severe cases due to its lower mortality rates, despite higher hospitalization costs and longer stays.
View Article and Find Full Text PDF

The purpose of this study was to analyse the clinical characteristics of patients with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) PCR re-positivity after recovering from coronavirus disease 2019 (COVID-19). Patients ( = 1391) from Guangzhou, China, who had recovered from COVID-19 were recruited between 7 September 2021 and 11 March 2022. Data on epidemiology, symptoms, laboratory test results and treatment were analysed.

View Article and Find Full Text PDF

Public health measures (such as wearing masks, physical distancing, and isolation) have significantly reduced the spread of the coronavirus disease-2019 (COVID-19), but the impact of public health measures on other respiratory infectious diseases is unclear. To assess the correlation between public health measures and the incidence of respiratory infectious diseases in China during the COVID-19 pandemic. We collected the data from the National Health and Construction Commission in China on the number of patients with six respiratory infectious diseases (measles, tuberculosis, pertussis, scarlet fever, influenza, and mumps) from 2017 to 2020 and assessed the correlation between public health measures and the incidence of respiratory infectious diseases.

View Article and Find Full Text PDF